Joel H. Vazquez

Statistics

Publications

Citations

190

H-Index

Active since

2019

Affiliations

University of Arkansas for Medical Sciences(Current)

Washington University in St. Louis

University of Kansas Medical Center

Joel H. Vazquez is an author at University of Arkansas for Medical Sciences specializing in pharmacology, life sciences, and biomarkers of liver injury.

ORCID

Publications per year

2019–2023

Publications

Proteomics Indicates Lactate Dehydrogenase Is Prognostic in Acetaminophen-Induced Acute Liver Failure Patients and Reveals Altered Signaling Pathways

Joel H. Vazquez, Stefanie Kennon‐McGill, Stephanie D. Byrum et al. · Toxicological Sciences · 2022 · 37 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration

Laura Ewing, Mitchell R. McGill, Eric U. Yee et al. · Molecules · 2019 · 36 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Identification of Serum Biomarkers to Distinguish Hazardous and Benign Aminotransferase Elevations

Joel H. Vazquez, Melissa M. Clemens, Felicia D. Allard et al. · Toxicological Sciences · 2019 · 30 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult

Nicole K.H. Yiew, Joel H. Vazquez, Michael R. Martino et al. · Molecular Metabolism · 2023 · 25 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis

Mitchell R. McGill, Laura P. James, Sandra McCullough et al. · Hepatology Communications · 2021 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

1–5 of 7